Each year, hundreds of thousands of horseshoe crabs are netted and drained of their milky-blue blood. It’s used for medical safety tests that detect bacterial contamination in drugs and implants. According to a recent Reuters article, activists from The National Audubon Society, Defenders of Wildlife, and other groups are pressuring the pharmaceutical industry to switch to a synthetic version of the blood, known as recombinant Factor C (rFC).
Quick Hits: Wildlife Activists Target Big Pharma for Using Too Much Crab Blood
Wildlife advocates want drugmakers to cease use of horseshoe crab blood in favor of a synthetic alternative.
Jun 24, 2020
Fresh from the show floor: pharma packaging innovations for 2026
Serialization mandates. Containment demands. Sterile barrier requirements. Our editors found the pharma packaging innovations addressing your biggest challenges at PACK EXPO Las Vegas. Get your free curated report now.
GET YOUR COPY
Downloads


















